Zacks Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Zacks Investment Management's ELV Position: Q3 2025 in Review
Zacks Investment Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 849 shares — an estimated $330K sold.
Zacks Investment Management first reported a position in ELV in Q3 2015 and held it in 14 quarters. The position peaked at $8.46M in Q2 2023. 1,512 funds tracked by Wall St. Rank hold ELV as of Q3 2025.
- Zacks Investment Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
- Zacks Investment Management sold 849 Elevance Health shares in Q3 2025, an estimated $330K.
- Zacks Investment Management first reported a position in Elevance Health in Q3 2015 and held it in 14 quarters.
- Zacks Investment Management's Elevance Health position peaked at $8.46M in Q2 2023.
- 1,512 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.
Based on Zacks Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.